Regulatory Risk Monitor ongoing securities litigation and potential regulatory scrutiny tied to Taro to anticipate governance or sanctions-related procurement constraints that could impact timing and budgeting for new product initiatives or supplier contracts.

Healthcare M&A Leverage recent and historical M&A activity, including Sun’s past interests and SPV-driven mergers, to position integrated pharma solutions, due-diligence services, and post-merger integration offerings that align with Taro's strategic expansion plans.

Speclty Growth Target their niche-focused portfolio with high-margin potential by proposing advanced manufacturing efficiency, contract development and manufacturing organization (CDMO) partnerships, and specialty formulation services that preserve premium margins.

Data Security Address recent data breach investigations by offering robust cybersecurity for manufacturing IT, ERP integrity, and supplier data protection to reduce risk in vendor ecosystems and support continuity of supply.

Acquisition Readiness Capitalize on Proactiv and SPV-related consolidation activity by offering integration services, ERP and SAP optimization, and scalability solutions to support potential future acquisitions or portfolio rationalizations.